In addition, KEGG pathway analysis shows significant changes in genes involved in the PI3K-Akt, cAMP, MAPK, Wnt, JAK-STAT, TLR, IL-17, TGF-β, and chemokine-related signaling pathways in DLBCL patients, suggesting significant alterations in multiple signaling transduction pathways in DLBCL patient cells. The gene discussed is IL17A; the disease is diffuse large B-cell lymphoma.